{
    "2021-02-03": [
        [
            {
                "time": "2021-02-05",
                "original_text": "AbbVie Stock Tops Buy Zone On Earnings Beat, Strong 2021 Guidance",
                "features": {
                    "keywords": [
                        "Earnings Beat",
                        "Strong 2021 Guidance",
                        "Buy Zone"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "Here's Why Investors Liked AbbVie's Q4 Results",
                "features": {
                    "keywords": [
                        "Investors Liked",
                        "Q4 Results"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "AbbVie Lands In Buy Zone On Earnings Beat, Strong 2021 Guidance",
                "features": {
                    "keywords": [
                        "Buy Zone",
                        "Earnings Beat",
                        "Strong 2021 Guidance"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "AbbVie’s 4Q Profit Tops Analysts’ Estimates; Shares Gain",
                "features": {
                    "keywords": [
                        "4Q Profit",
                        "Tops Estimates",
                        "Shares Gain"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "AbbVie (ABBV) Q4 Earnings & Sales Top, 2021 Outlook Bright",
                "features": {
                    "keywords": [
                        "Q4 Earnings",
                        "Sales Top",
                        "2021 Outlook Bright"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "Unusual Options Activity Insight: AbbVie",
                "features": {
                    "keywords": [
                        "Unusual Options Activity",
                        "Insight"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "With Clock Ticking on Humira, AbbVie Plans for 2021 Growth",
                "features": {
                    "keywords": [
                        "Clock Ticking",
                        "Humira",
                        "2021 Growth"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "AbbVie (ABBV) Q4 Earnings and Revenues Surpass Estimates",
                "features": {
                    "keywords": [
                        "Q4 Earnings",
                        "Revenues Surpass Estimates"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "AbbVie Stock: AbbVie Earnings Top Estimates, Guidance Strong",
                "features": {
                    "keywords": [
                        "Earnings Top Estimates",
                        "Guidance Strong"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "AbbVie: Q4 Earnings Insights",
                "features": {
                    "keywords": [
                        "Q4 Earnings Insights"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "AbbVie stock rallies after profit and revenue beats, upbeat outlook",
                "features": {
                    "keywords": [
                        "Profit Beats",
                        "Revenue Beats",
                        "Upbeat Outlook"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "AbbVie Reports Full-Year and Fourth-Quarter 2020 Financial Results",
                "features": {
                    "keywords": [
                        "Full-Year",
                        "Fourth-Quarter 2020",
                        "Financial Results"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision",
                "features": {
                    "keywords": [
                        "Amgen Earnings",
                        "GSK-CureVac Vaccine",
                        "Mallinckrodt FDA Decision"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "vaccines"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "AbbVie Beats Earnings Expectations as Sales Surge",
                "features": {
                    "keywords": [
                        "Beats Earnings Expectations",
                        "Sales Surge"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}